Special focus issue on the annual meeting of the British Society for Gene and Cell Therapy. (2015)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/hum.2015.2500
PubMed Identifier: 25989311
Publication URI: http://europepmc.org/abstract/MED/25989311
Type: Journal Article/Review
Volume: 26
Parent Publication: Human gene therapy
Issue: 5
ISSN: 1043-0342